Stay updated on Durvalumab Combos Post-Chemo-Radiation in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combos Post-Chemo-Radiation in Lung Cancer Clinical Trial page.

Latest updates to the Durvalumab Combos Post-Chemo-Radiation in Lung Cancer Clinical Trial page
- Check4 days agoChange DetectedA new revision entry v3.6.5 appears in the page history, replacing the previous v3.6.4, indicating an update to the record history metadata.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedA new site revision is recorded (v3.6.4), replacing the previous v3.6.3 in the history. This indicates a new build of the ClinicalTrials.gov interface.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedThe history now shows a new site revision, v3.6.3, replacing the previous v3.6.2. This reflects a platform update rather than changes to the trial record data.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page's revision tag updated from v3.6.0 to v3.6.2, indicating a new platform release.SummaryDifference0.1%

- Check54 days agoChange DetectedThe record history now includes a new 2026-06-18 update with a Study Status entry. The 2026-06-17 entry follows, and the 2026-05-18 entry has been deleted, indicating a revision to the version history.SummaryDifference0.2%

- Check61 days agoChange DetectedAdded the recruitment status 'No longer looking for participants' and updated the version history to include 'Revision: v3.6.0' while removing 'Revision: v3.5.5'.SummaryDifference0.2%

Stay in the know with updates to Durvalumab Combos Post-Chemo-Radiation in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combos Post-Chemo-Radiation in Lung Cancer Clinical Trial page.